Dr Shahar Shelly | Neurology | Best Researcher Award |

Rambam Medical Center,Israel

Professional Profiles:

👨‍🎓 Bio Summary:

Dr. Shahar Shelly is a renowned neurologist and researcher specializing in neuroimmunology, neuromuscular disorders, and cutting-edge diagnostic and therapeutic approaches. He is the Chair of the Neurology Department at Rambam Medical Center and serves as the President of Israel’s Neuromuscular Society. Dr. Shelly is also an Assistant Professor at the Technion Institute of Medicine and Science and the Mayo Clinic College of Medicine. With a proven track record of groundbreaking research, leadership, and clinical excellence, he is dedicated to advancing the understanding and treatment of neurological diseases.

🎓 Educational Background:

Dr. Shelly completed his medical education at the University Medical School of Hungary, graduating Summa Cum Laude in 2012. He pursued an internship at Shamir Medical Center in Israel, earning Cum Laude honors. His advanced training includes a residency in neurology at Sheba Medical Center, followed by prestigious fellowships at Mayo Clinic in neuroimmunology and neuromuscular disorders, where he gained expertise in electrophysiology, nerve, and muscle diagnostics.

🔍 Research Focus:

Dr. Shelly’s research integrates big data analytics with molecular biology to uncover biomarkers and therapeutic targets for neurological disorders. His work spans early disease diagnosis, immune-modulating therapy response, and potential gene knockdown treatments. Notable achievements include discovering a patentable antigen, Neurochondrin, and conducting influential studies on the impact of titanium nanoparticles on the blood-brain barrier. His research aims to bridge the gap between laboratory discoveries and clinical applications.

🏆 Honors & Awards:

Dr. Shelly has received numerous accolades, including the Israel Medical Association Fellowship Award for outstanding promise in medicine, the Molivich Award for clinical and research excellence, and the Best Abstract and Research Study Award from the American Academy of Neurology. He has also been recognized for his exceptional academic achievements, such as ranking first in his neurology board exams and receiving Summa Cum Laude honors during his medical studies.

💼 Professional Experience:

Dr. Shelly has held various leadership roles, including Chair of the Neurology Department and Head of the Neuromuscular Division at Rambam Medical Center. He also leads the Neuroimmunology Laboratory at the Technion Institute of Medicine and is a regional board representative for hereditary muscle diseases for the RYR1 Foundation. As a faculty member at the Mayo Clinic and Technion Institute, he combines clinical practice with education and research, mentoring the next generation of neurologists.

📚 Top Noted Publications :

Prolactin and Autoimmunity

Authors: S. Shelly, M. Boaz, H. Orbach

Journal: Autoimmunity Reviews

Citations: 306

Index: 11(6-7), A465-A470

Year: 2012

Autonomic Dysfunction Following COVID-19 Infection: An Early Experience

Authors: K. Shouman, G. Vanichkachorn, W.P. Cheshire, M.D. Suarez, S. Shelly, et al.

Journal: Clinical Autonomic Research

Citations: 286

Index: 31, 385-394

Year: 2021

Thymoma and Autoimmunity

Authors: S. Shelly, N. Agmon-Levin, A. Altman, Y. Shoenfeld

Journal: Cellular & Molecular Immunology

Citations: 238

Index: 8(3), 199-202

Year: 2011

Immune Checkpoint Inhibitor-Associated Myopathy: A Clinicoseropathologically Distinct Myopathy

Authors: S. Shelly, J.D. Triplett, M.V. Pinto, M. Milone, F.E. Diehn, A. Zekeridou, et al.

Journal: Brain Communications

Citations: 77

Index: 2(2), fcaa181

Year: 2020

Epidemiology and Natural History of Inclusion Body Myositis: A 40-Year Population-Based Study

Authors: S. Shelly, M.M. Mielke, J. Mandrekar, M. Milone, F.C. Ernste, E. Naddaf, et al.

Journal: Neurology

Citations: 54

Index: 96(21), e2653-e2661

Year: 2021

Conclusion:

Dr. Shahar Shelly is a highly suitable candidate for the Best Researcher Award, given his outstanding research accomplishments, leadership, and innovative contributions to neurology and neuroimmunology. His ability to integrate cutting-edge methodologies, such as big data and molecular insights, with a strong focus on translational medicine sets him apart as a leader in his field. Addressing the areas for improvement can further solidify his standing as a globally recognized researcher.